StreetAlpha.app
Home › Stocks › CVS

CVS HEALTH Corp (CVS)

Healthcare
$80.84
▲ +1.00%
LAST CLOSE · NOV 20

CVS Health runs retail pharmacies, medical clinics and health insurance plans for patients, employers and government programs. It last closed at $80.84 on Nov 20, up 1.00% on the day. The next earnings report for CVS is expected around Tue, Feb 9, 2027. For the quarter ended Sep 2026, CVS reported EPS of $1.68 on revenue of $108.40B, with revenue up 5.4% from a year ago. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months CVS insiders bought $2.0M of stock on the open market and sold $323.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is CVS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CVS.

Key Stats

Last 12 months
Results
Revenue
$421B
+6.7% vs a year ago
Net income
$11.0B
+2253.3% vs a year ago
EPS (diluted)
$8.61
+2165.8% vs a year ago
Free cash flow
$15.6B
3.7% margin
Valuation
Market cap
$103B
1.28B shares
P/E
9.4
Price over 12 month EPS
Price to sales
0.2
Market cap over revenue
Dividend yield
3.29%
$2.66 a share over 12 months
Balance sheet
Cash & equivalents
$11.7B
At Sep 30
Shareholder equity
$80.5B
Shares outstanding
1.28B
At Oct 28
CEODavid Joyner
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $292B$292BFY2021FY2022: $322B$322BFY2022FY2023: $358B$358BFY2023FY2024: $373B$373BFY2024FY2025: $402B$402BFY2025

From CVS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 9
Estimated date · Time not announced
Reported EPS
$1.68
Quarter ended Sep 2026
Year ago EPS
-$3.13
Same quarter last year
Revenue
$108.40B
+5.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.31Dec '24Mar 2025: $1.41Mar '25Jun 2025: $0.80Jun '25Sep 2025: -$3.13Sep '25Dec 2025: $2.32Dec '25Mar 2026: $2.30Mar '26Jun 2026: $2.31Jun '26Sep 2026: $1.68Sep '26Latest $1.68
Revenue by quarter
Dec 2024: $97.71BDec '24Mar 2025: $94.59BMar '25Jun 2025: $98.92BJun '25Sep 2025: $102.87BSep '25Dec 2025: $105.69BDec '25Mar 2026: $100.43BMar '26Jun 2026: $106.10BJun '26Sep 2026: $108.40BSep '26Latest $108.40B
How CVS moved after its last 8 reports
Average move the session after a report ±5.8%
Nov 4, 2026Time not announced−12.5%
Aug 5, 2026Time not announced−5.1%
May 6, 2026Time not announced+7.7%
Feb 10, 2026Time not announced−0.1%
Oct 29, 2025Time not announced−1.9%
Jul 31, 2025Time not announced−0.3%
May 1, 2025Time not announced+4.1%
Feb 12, 2025Time not announced+14.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CVSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on CVS: 0 upgrades, 0 downgrades, 0 initiations · Targets mentioned $108.00
Royal Bank Of CanadaTarget cut
Nov 16 $108.00

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on CVS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CVS

Technical Analysis

CVS · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 8% below its 20 day and 9% below its 50 day average. It is 11% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot S1 at $80.24, and the nearest resistance the Pivot at $81.27.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 3.8%/day
Key levels
$110.6852 week high+36.9%
$94.26100 day average+16.6%
$89.93Swing high (Oct 7)+11.2%
$89.36200 day average+10.5%
$88.4350 day average+9.4%
$86.9420 day average+7.5%
$81.88Pivot R1+1.3%
$81.27Pivot+0.5%
$80.84Last close
$80.24Pivot S1−0.7%
$77.33Swing low (Nov 4)−4.3%
$69.5152 week low−14.0%
Indicators
RSI (14)36.71Weak, oversold below 30Neutral
MACD-1.94Below its signal lineBearish
Stochastic23.4Middle of its rangeNeutral
ADX (14)23.4Weak trend
Williams %R-75.9Oversold below −80, overbought above −20Neutral
CCI (20)-107.2Oversold below −100, overbought above 100Oversold
Rate of change−3.6%Change over 10 sessionsBearish
ATR (14)$3.11Typical daily range, 3.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CVS

What happened before

See how CVS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CVS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CVS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CVSHow many large options trades hit CVS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

CVS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ●930 buying vs 944 selling
  • ▼Held by funds -2.4 pts
  • ▼Funds holding -84
  • ▼Superinvestors: 1 added, 5 cut
  • ▼Put/call 1.05 to 1.34
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,0012,085−4.0%
In funds' top 101631−48.4%
Held by funds86.8%89.2%−2.4 pts
New / increased139 / 791301 / 762−12.5%
Reduced / sold out741 / 203736 / 110+11.6%
Put/call ratio1.341.05+28.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CVS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CVS Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$2.0M1 buy · 1 insider
Sold$323.7M2 sales · 2 insiders
2026-05 sold $323.7M2026-11 bought $2.0MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 6Prem S ShahEVP and Group PresidentBuy23,855$83.89$2.0M
May 21Larry RobbinsDirectorSale3,372,000$94.15$317.5M
May 8Tilak MandadiEVP, Chief Exp & Tech OfficerSale69,551$89.58$6.2M
Aug 20, 2025Anne A. FinucaneDirectorSale7,500$71.02$533K
Jun 5, 2025Guy P SansoneDirectorBuy1,570$63.70$100K
May 6, 2025Larry RobbinsDirectorSale3,750,000$67.66$253.7M
Every insider buy and sale for CVS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CVS insider trades →

From SEC Form 4 filings by CVS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

CVS Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$11.5B
11.1% of value
Shares outstanding, 12 months
+0.8%
More shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $3.0B
Dec 2023: $0Mar 2024: $3.0B, average price $75.57Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $0Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CVS is in one of them and how their past CVS trades turned out.

CVS in the AI portfolios
Loading…

CVS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CVS in an article yet. Here's the latest on the wider market.

CVS in the news

CVS Congress Trades

All congress trades →
Trades, 12 months
9
Buys
3
33%
Sells
6
67%
People
5
Last filed Nov 5
Who traded CVS · since 2014
Latest 5 filings of 198
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
Ro KhannaSell (partial)
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$15K – $50KTraded Sep 4, 2026Filed Oct 7, 2026
Ro KhannaSell (partial)
$1K – $15KTraded Aug 24, 2026Filed Sep 4, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell (partial)$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$15K – $50KSep 4, 2026Oct 7, 202633 d
Ro KhannaD · CASell (partial)$1K – $15KAug 24, 2026Sep 4, 202611 d
Alan ArmstrongR · OKBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About CVS HEALTH

CVS Health is a health care company based in Woonsocket, Rhode Island. It runs retail drugstores and medical clinics, operates a pharmacy benefits manager, and sells health insurance plans, including Medicare Advantage and Medicare prescription drug plans. Its customers include patients who use its stores and clinics, plan members, employer groups and government programs.

Headquarters
Woonsocket, RI
Founded
1963